Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans ...
Nasdaq

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...
Seeking Alpha

Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued

Bristol-Myers Squibb remains a "Buy" despite recent price increases, with intrinsic value calculations showing the stock is still undervalued. The company faces risks from patent expirations but has ...
Business Wire

Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis ® (apixaban) Option

Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price Beginning September 8, eligible U.S. patients with an Eliquis prescription may ...
Seeking Alpha

Bristol-Myers Squibb: Buy The Weakness

Bristol-Myers Squibb faces political pressure on U.S. drug prices, but I see the risk as manageable given its strong fundamentals. The company’s growth portfolio now exceeds half of revenue, ...
Nasdaq

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
Forbes

Buy Bristol Myers Squibb Stock At $45?

Bristol-Myers Squibb (NYSE: BMY) has considerably lagged behind the overall market, with its stock decreasing by 20% this year, while the S&P 500 index has risen by 14%. This drop can be attributed in ...